In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice

被引:55
作者
Naganawa, T
Mao, L
Abogunde, E
Sobue, T
Kalajzic, I
Sabbieti, M
Agas, D
Hurley, MM [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA
[3] Univ Camerino, I-62032 Camerino, Italy
关键词
fibroblast growth factor-2; gene; haplo-insufficiency; mice; bones; DEXA; FGF receptor2; Runx2;
D O I
10.1016/j.bbrc.2005.10.215
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported that deletion of the Fgf2 gene (Fgf2-/-) resulted in decreased bone mass in adult mice. This study examines the effect of haplo-insuffiency (Fgf2+/-) on bone loss in vertebrae from these mutant mice. Fgf2+/+ mice attained peak bone mass at 89 months of age. In contrast BMD was significantly reduced in vertebrae from adult (8-9) Fgf2+/- mice. Exogenous FGF-2 rescued reduced bone nodule formation in Fgf2+/- and Fgf2-/- cultures. Runx2 mRNA was reduced in cultures from Fgf2+/- and Fgf2-/- mice. FGF receptor2 mRNA and protein were markedly reduced in Fgf2+/- and Fgf2-/- mice. Decreased bone formation in Fgf2 mutant mice may correlate with impaired FGFR signaling, decreased Runx2 gene expression. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:490 / 498
页数:9
相关论文
共 43 条
[1]  
BANERJEE U, 1997, LOOP TR RESTRUCT COM, V3, P1
[2]  
CHEN JK, 1992, J BONE MINER RES, V7, P987
[3]   ABNORMAL BONE-GROWTH AND SELECTIVE TRANSLATIONAL REGULATION IN BASIC FIBROBLAST GROWTH-FACTOR (FGF-2) TRANSGENIC MICE [J].
COFFIN, JD ;
FLORKIEWICZ, RZ ;
NEUMANN, J ;
MORTHOPKINS, T ;
DORN, GW ;
LIGHTFOOT, P ;
GERMAN, R ;
HOWLES, PN ;
KIER, A ;
OTOOLE, BA ;
SASSE, J ;
GONZALEZ, AM ;
BAIRD, A ;
DOETSCHMAN, T .
MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (12) :1861-1873
[4]   Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 [J].
Colvin, JS ;
Bohne, BA ;
Harding, GW ;
McEwen, DG ;
Ornitz, DM .
NATURE GENETICS, 1996, 12 (04) :390-397
[5]   Osteopenia and decreased bone formation in osteonectin-deficient mice [J].
Delany, AM ;
Amling, M ;
Priemel, M ;
Howe, C ;
Baron, R ;
Canalis, E .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) :915-923
[6]   Basic fibroblast growth factor destabilizes osteonectin mRNA in osteoblasts [J].
Delany, AM ;
Canalis, E .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (03) :C734-C740
[7]   Fibroblast growth factor receptor 3 is a negative regulator of bone growth [J].
Deng, CX ;
WynshawBoris, A ;
Zhou, F ;
Kuo, A ;
Leder, P .
CELL, 1996, 84 (06) :911-921
[8]   Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation [J].
Ducy, P ;
Zhang, R ;
Geoffroy, V ;
Ridall, AL ;
Karsenty, G .
CELL, 1997, 89 (05) :747-754
[9]   Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats [J].
Dunstan, CR ;
Boyce, R ;
Boyce, BF ;
Garrett, IR ;
Izbicka, E ;
Burgess, WH ;
Mundy, GR .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (06) :953-959
[10]  
Friedenstein A. J., 1990, BONE MINER RES, P243, DOI 10.1016/B978-0-444-81371-8.50012-1